Application 202033

Type: ANDA
Sponsor: MYLAN PHARMS INC

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	METOPROLOL SUCCINATE	METOPROLOL SUCCINATE	TABLET, EXTENDED RELEASE;ORAL	EQ 25MG TARTRATE	No	No
002	METOPROLOL SUCCINATE	METOPROLOL SUCCINATE	TABLET, EXTENDED RELEASE;ORAL	EQ 50MG TARTRATE	No	No
003	METOPROLOL SUCCINATE	METOPROLOL SUCCINATE	TABLET, EXTENDED RELEASE;ORAL	EQ 100MG TARTRATE	No	No
004	METOPROLOL SUCCINATE	METOPROLOL SUCCINATE	TABLET, EXTENDED RELEASE;ORAL	EQ 200MG TARTRATE	No	No

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
0378-4595	Metoprolol Succinate	metoprolol succinate	Mylan Pharmaceuticals Inc.	ANDA	Current
0378-4595	Metoprolol Succinate	metoprolol succinate	Mylan Pharmaceuticals Inc.	ANDA	Current
0378-4595	Metoprolol Succinate	metoprolol succinate	Mylan Pharmaceuticals Inc.	ANDA	Current
0378-4596	Metoprolol Succinate	metoprolol succinate	Mylan Pharmaceuticals Inc.	ANDA	Current
0378-4596	Metoprolol Succinate	metoprolol succinate	Mylan Pharmaceuticals Inc.	ANDA	Current
0378-4596	Metoprolol Succinate	metoprolol succinate	Mylan Pharmaceuticals Inc.	ANDA	Current
0378-4597	Metoprolol Succinate	metoprolol succinate	Mylan Pharmaceuticals Inc.	ANDA	Current
0378-4597	Metoprolol Succinate	metoprolol succinate	Mylan Pharmaceuticals Inc.	ANDA	Current
0378-4597	Metoprolol Succinate	metoprolol succinate	Mylan Pharmaceuticals Inc.	ANDA	Current
0378-4598	Metoprolol Succinate	metoprolol succinate	Mylan Pharmaceuticals Inc.	ANDA	Current
0378-4598	Metoprolol Succinate	metoprolol succinate	Mylan Pharmaceuticals Inc.	ANDA	Current
0378-4598	Metoprolol Succinate	metoprolol succinate	Mylan Pharmaceuticals Inc.	ANDA	Current
51079-169	Metoprolol Succinate	metoprolol succinate	Mylan Institutional Inc.	ANDA	Current
51079-169	Metoprolol Succinate	metoprolol succinate	Mylan Institutional Inc.	ANDA	Current
51079-169	Metoprolol Succinate	metoprolol succinate	Mylan Institutional	ANDA	Current
51079-169	Metoprolol Succinate	metoprolol succinate	Mylan Institutional Inc.	ANDA	Current
51079-170	Metoprolol Succinate	metoprolol succinate	Mylan Institutional Inc.	ANDA	Current
51079-170	Metoprolol Succinate	metoprolol succinate	Mylan Institutional	ANDA	Current
51079-170	Metoprolol Succinate	metoprolol succinate	Mylan Institutional Inc.	ANDA	Current
51079-170	Metoprolol Succinate	metoprolol succinate	Mylan Institutional Inc.	ANDA	Current
51079-171	Metoprolol Succinate	metoprolol succinate	Mylan Institutional	ANDA	Current
51079-171	Metoprolol Succinate	metoprolol succinate	Mylan Institutional Inc.	ANDA	Current
51079-171	Metoprolol Succinate	metoprolol succinate	Mylan Institutional Inc.	ANDA	Current
55154-4385	Metoprolol Succinate	metoprolol succinate	Cardinal Health	ANDA	Current
55154-4385	Metoprolol Succinate	metoprolol succinate	Cardinal Health	ANDA	Current
55154-4385	Metoprolol Succinate	metoprolol succinate	Cardinal Health	ANDA	Current
55154-4388	Metoprolol Succinate	metoprolol succinate	Cardinal Health	ANDA	Current
55154-4388	Metoprolol Succinate	metoprolol succinate	Cardinal Health	ANDA	Current
55154-4388	Metoprolol Succinate	metoprolol succinate	Cardinal Health	ANDA	Current

Application 202033

Related Records#

Application Products#

NDC Listings For This Application#